The vitamin D supplement you take every day. It was recommended by your doctor because it is 'scientifically backed.' The study that served as the basis: a large-scale randomized controlled trial of ...
That morning, the HR director reported to the management team with a smile: "The leadership training has been effective. Participant engagement scores have risen significantly. The p-value is 0.03." A ...
CBL-514 delivered statistically significant pain reduction across both FAS and PP populations compared with placebo.
Long-term exposure to air pollution is linked to higher suicide risk, raising questions about the role of environment in ...
Newsable Asianet News on MSN
ACAD Stock Tumbles Today: Analysts Weigh RADIANT Results, Cut Price Targets
Acadia's latest trial update has put the spotlight on remlifanserin's development path, prompting analysts to reassess its ...
Acadia Pharmaceuticals' (ACAD) favorable risk-reward remains intact despite remlifanserin narrowly missing statistical significance in a phase 2 trial in Alzheimer's disease psych ...
Acadia stock tumbled Thursday after the company's experimental Alzheimer's disease psychosis treatment missed the mark.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
One of the most persistent hopes in preventive medicine has been that a simple nutrient taken during pregnancy could lay the ...
Acadia Pharmaceuticals announced topline results from the Phase 2 portion of the ongoing RADIANT clinical trial program evaluating Remlifanserin in patients with Alzheimer's disea ...
Primary aldosteronism has long been described as the hidden epidemic of cardiovascular medicine. It is the most common form ...
Yesterday, September 24, the FDA approved the combination of belzutifan (WELIREG; Merck) plus lenvatinib (LENVIMA; Eisai) to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results